Sharma East India Hospitals & Medical Research (BOM:524548) Cyclically Adjusted Revenue per Share: ₹76.55 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524548 Sharma East India Hospitals & Medical Research Ltd BOM:524548
73 GF Score
Price ₹94.58
GF Value ₹107.71
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Sharma East India Hospitals & Medical Research Cyclically Adjusted Revenue per Share?

Sharma East India Hospitals & Medical Research BOM:524548 +0.35% 73 Cyclically Adjusted Revenue per Share is ₹76.55 as of Jun. 2026. GuruFocus rates BOM:524548 with a GF Score™ of 73/100 and a GF Value™ of ₹107.71 (Modestly Undervalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Sharma East India Hospitals & Medical Research's adjusted revenue per share for the three months ended in Jun. 2026 was ₹32.680. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹76.55 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Sharma East India Hospitals & Medical Research's average Cyclically Adjusted Revenue Growth Rate was -2.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-09-02), Sharma East India Hospitals & Medical Research's current stock price is ₹94.58. Sharma East India Hospitals & Medical Research's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was ₹76.55. Sharma East India Hospitals & Medical Research's Cyclically Adjusted PS Ratio of today is 1.24.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Sharma East India Hospitals & Medical Research was 2.79. The lowest was 0.89. And the median was 1.27.


Sharma East India Hospitals & Medical Research  (BOM:524548) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Sharma East India Hospitals & Medical Research's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=94.58/76.55
=1.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Sharma East India Hospitals & Medical Research was 2.79. The lowest was 0.89. And the median was 1.27.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Sharma East India Hospitals & Medical Research Cyclically Adjusted Revenue per Share Related Terms


Sharma East India Hospitals & Medical Research Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Sharma East India Hospitals & Medical Research's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sharma East India Hospitals & Medical Research Cyclically Adjusted Revenue per Share Chart

Sharma East India Hospitals & Medical Research Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 77.10 81.77

Sharma East India Hospitals & Medical Research Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 78.86 79.54 81.09 81.77 76.55

BOM:524548 vs HCA, THC, EHC: Cyclically Adjusted Revenue per Share Comparison

For the Medical Care Facilities subindustry, Sharma East India Hospitals & Medical Research's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sharma East India Hospitals & Medical Research Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Sharma East India Hospitals & Medical Research's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Sharma East India Hospitals & Medical Research's Cyclically Adjusted PS Ratio falls into.


BOM:524548
73GF Score
Sharma East India Hospitals & Medical Research Ltd BOM:524548
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sharma East India Hospitals & Medical Research Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sharma East India Hospitals & Medical Research's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=32.68/167.3573*167.3573
=32.680

Current CPI (Jun. 2026) = 167.3573.

Sharma East India Hospitals & Medical Research Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201512 12.362 102.901 20.105
201603 13.678 102.518 22.329
201606 17.150 105.961 27.087
201609 22.805 105.961 36.019
201612 11.270 105.196 17.930
201703 15.395 105.196 24.492
201706 14.713 107.109 22.989
201709 9.718 109.021 14.918
201712 10.452 109.404 15.989
201803 6.112 109.786 9.317
201903 0.000 118.202 0.000
201906 12.915 120.880 17.881
201909 12.251 123.175 16.645
201912 9.700 126.235 12.860
202003 11.982 124.705 16.080
202006 3.102 127.000 4.088
202009 7.555 130.118 9.717
202012 6.967 130.889 8.908
202103 6.426 131.771 8.161
202106 8.120 134.084 10.135
202109 13.757 135.847 16.948
202112 14.123 138.161 17.108
202203 15.765 138.822 19.006
202206 15.573 142.347 18.309
202209 15.386 144.661 17.800
202212 16.549 145.763 19.001
202303 15.510 146.865 17.674
202306 16.783 150.280 18.690
202309 16.297 151.492 18.004
202312 17.936 152.924 19.629
202403 5.458 153.035 5.969
202406 20.608 155.789 22.138
202409 27.435 157.882 29.081
202412 24.933 158.323 26.356
202503 18.266 157.552 19.403
202506 28.901 159.755 30.276
202509 28.646 162.289 29.541
202512 29.197 163.281 29.926
202603 22.790 164.272 23.218
202606 32.680 167.357 32.680

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ₹76.55 mean?
Sharma East India Hospitals & Medical Research (BOM:524548) has a Cyclically Adjusted Revenue per Share of ₹76.55 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Sharma East India Hospitals & Medical Research and its competitors.
Is Sharma East India Hospitals & Medical Research's Cyclically Adjusted Revenue per Share too high?
Sharma East India Hospitals & Medical Research's current Cyclically Adjusted Revenue per Share is ₹76.55. Overall, Sharma East India Hospitals & Medical Research has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sharma East India Hospitals & Medical Research's Cyclically Adjusted Revenue per Share compare to HCA and THC?
Sharma East India Hospitals & Medical Research's Cyclically Adjusted Revenue per Share of ₹76.55 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Sharma East India Hospitals & Medical Research and its competitors. Sharma East India Hospitals & Medical Research's current Cyclically Adjusted Revenue per Share is ₹76.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sharma East India Hospitals & Medical Research stock overvalued right now?
Based on GuruFocus' analysis, Sharma East India Hospitals & Medical Research (BOM:524548) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹107.71, compared to a current price of ₹94.58 — trading 12.2% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is ₹76.55. Sharma East India Hospitals & Medical Research's overall GF Score™ is 73/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Sharma East India Hospitals & Medical Research (BOM:524548), the current Cyclically Adjusted Revenue per Share is ₹76.55 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sharma East India Hospitals & Medical Research (BOM:524548) Overvalued in 2026?

Based on GuruFocus' analysis, Sharma East India Hospitals & Medical Research stock appears to be undervalued. The current stock price of ₹94.58 is trading 12.2% below its estimated GF Value™ of ₹107.71. GuruFocus considers Sharma East India Hospitals & Medical Research to be Modestly Undervalued.

Key valuation signals for BOM:524548:

  • Cyclically Adjusted Revenue per Share: ₹76.55
  • GF Value™: ₹107.71 vs. price of ₹94.58 (12.2% below fair value)
  • GF Score™: 73/100 with 6 warning signs

No single metric tells the full story. See the BOM:524548 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sharma East India Hospitals & Medical Research Business Description

Address Tonk Road, Jaipur Hospital, Lal Kothi, Near S.M.S. Stadium, Jaipur, RJ, IND, 302015
Sharma East India Hospitals & Medical Research Ltd is engaged in service activities related to the medical and healthcare services and real estate services. It provides healthcare services through the multi-specialty hospital in the name of Jaipur Hospital in Rajasthan. It provides services like joint replacement surgery, arthroscopy, cardiothoracic and vascular surgery, interventional cardiology, such as angiography and angioplasty, neurosurgery, and others.
73GF Score

Get the complete analysis for BOM:524548

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹94.58
Price
₹107.71
GF Value